ditiocarb has been researched along with Drug Withdrawal Symptoms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Li, C; Li, S; Liang, J; Liu, S; Liu, T; Song, Z; Tang, C; Xu, N; Zhou, S; Zhu, L | 1 |
| Bhateja, P; Rehni, AK; Singh, N; Singh, TG | 1 |
2 other study(ies) available for ditiocarb and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis.
Topics: Alcoholism; Amino Acid Transport System y+; Animals; Cell Line, Tumor; Copper; Disulfiram; Ditiocarb; Ferroptosis; Humans; Melanoma; Metal-Organic Frameworks; Substance Withdrawal Syndrome | 2023 |
Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Ditiocarb; Dose-Response Relationship, Drug; Drug Interactions; Female; Male; Mice; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; NF-kappa B; Opioid-Related Disorders; Severity of Illness Index; Substance Withdrawal Syndrome | 2008 |